Medication info
Bugwang Brivaracetam 25 mg Tablets (Brivaracetam)

Bugwang Brivaracetam 25 mg Tablets (Brivaracetam)

Prescription medicationTabletOral
Ingredient · strength
Brivaracetam›25mg / 1 tablet
Manufacturer / importer
Bugwang Pharmaceutical Co., Ltd.
Appearance
Gray oval film-coated tablet
Packaging
30 tablets per bottle, 120 tablets per bottle
Approval status
Active

MFDS item code 202502485 · Approved 2025.09.19

Summary

Main use
Adjunctive treatment of partial-onset seizures in patients with epilepsy aged 16 years and older
Who takes it
Adults
Adult dose
This medicine is taken twice daily. The recommended initial dose is 25mg or 50mg per dose, based on the healthcare professional's assessment of potential adverse effects relative to seizure reduction. Based on clinical response and tolerability, the dose may be increased or decreased from 50mg per day [25mg per dose, twice daily] to 200mg per day [100mg per dose, twice daily]. Swallow this film-coated tablet whole with water. It may be taken with or without food. If you miss a dose If you miss one or more doses, take one dose as soon as you remember, and then take the next dose at the next scheduled morning or evening time. Discontinuation If you wish to stop taking this medicine, gradually reduce the dose by 50mg per day at 1-week intervals. After taking 50mg per day for 1 week, a dose of 20mg per day is recommended for the final week (see section 2. Warnings). Older adults (65 years and older) No dosage adjustment is required in older adults. Clinical experience in patients aged 65 years or older is limited. Renal impairment No dosage adjustment is required in patients with renal impairment. This medicine is not recommended for patients with end-stage renal impairment who are receiving hemodialysis. Hepatic impairment Exposure to this medicine is increased in patients with hepatic impairment. The recommended initial dose for patients with hepatic impairment is 50mg per day [25mg per dose, twice daily], and the recommended maximum dose is 150mg per day [75mg per dose, twice daily].

Ingredients

Manufacturer
Bugwang Pharmaceutical Co., Ltd.

Efficacy & effects

Adjunctive treatment of partial-onset seizures in patients with epilepsy aged 16 years and older

  • Epilepsy
  • secondary generalized seizures
  • partial seizures
View approved original text

This medication is used as an adjunctive treatment for partial seizures occurring in patients with epilepsy aged 16 years and older, whether or not secondary generalized seizures are present. It helps to reduce the frequency of seizures and improve symptoms when taken alongside the primary medication. This adjunctive therapy contributes to maintaining a more stable daily life for patients. It is taken safely and assists in enhancing the therapeutic effect.

How to take

Adult dose

This medicine is taken twice daily. The recommended initial dose is 25mg or 50mg per dose, based on the healthcare professional's assessment of potential adverse effects relative to seizure reduction. Based on clinical response and tolerability, the dose may be increased or decreased from 50mg per day [25mg per dose, twice daily] to 200mg per day [100mg per dose, twice daily]. Swallow this film-coated tablet whole with water. It may be taken with or without food. If you miss a dose If you miss one or more doses, take one dose as soon as you remember, and then take the next dose at the next scheduled morning or evening time. Discontinuation If you wish to stop taking this medicine, gradually reduce the dose by 50mg per day at 1-week intervals. After taking 50mg per day for 1 week, a dose of 20mg per day is recommended for the final week (see section 2. Warnings). Older adults (65 years and older) No dosage adjustment is required in older adults. Clinical experience in patients aged 65 years or older is limited. Renal impairment No dosage adjustment is required in patients with renal impairment. This medicine is not recommended for patients with end-stage renal impairment who are receiving hemodialysis. Hepatic impairment Exposure to this medicine is increased in patients with hepatic impairment. The recommended initial dose for patients with hepatic impairment is 50mg per day [25mg per dose, twice daily], and the recommended maximum dose is 150mg per day [75mg per dose, twice daily].

Precautions

This medication may cause mental health issues such as suicidal thoughts and behaviors, so it is important to consult a doctor immediately if any mood changes or unusual behaviors occur during use. This medication may cause neurological symptoms such as drowsiness, fatigue, and dizziness, so caution is advised when driving or operating machinery. Do not abruptly discontinue this medication; it should be gradually reduced according to a physician's instructions to prevent worsening seizures. Patients with allergies to the ingredients or certain genetic issues such as lactose intolerance should not take this medication. Patients with impaired liver function may require dosage adjustments when using this medication, so consultation with a doctor is necessary. While taking this medication, unusual reactions such as infections, depression, anxiety, and suicidal thoughts may occur, so symptoms should be monitored closely. If severe rashes or red spots develop on the skin, discontinue use immediately and inform a doctor. Taking this medication with alcohol may worsen psychomotor impairment, so it is advisable to avoid alcohol consumption. This medication may interact with other drugs, so it is vital to inform your physician or pharmacist of any other medications being taken. Women who are pregnant or breastfeeding should consult a physician before taking this medication, and careful consideration is also needed if planning to become pregnant. It is recommended not to use this medication in children under 16 years of age as its safety and efficacy have not been established. During the initial stages of taking this medication, drowsiness or dizziness may frequently occur; if these symptoms are severe, consult a doctor. In cases of overdose, severe drowsiness, dizziness, anxiety, and depression may appear, so the prescribed dosage should be strictly adhered to, and in case of overdose, immediate medical attention is required. Keep out of reach of children, and do not transfer the medication to other containers for safety.

Side effects

  • suicidal thoughts
  • suicidal behavior
  • drowsiness
  • fatigue
  • dizziness
  • akathisia
  • influenza
  • type 1 hypersensitivity reaction
  • neutropenia
  • decreased appetite
Show 20 more
  • depression
  • anxiety
  • irritability
  • insomnia
  • psychotic symptoms
  • aggression
  • restlessness
  • seizures
  • vertigo
  • upper respiratory infection
  • cough
  • nausea
  • vomiting
  • constipation
  • Stevens-Johnson syndrome (SJS)
  • tinnitus
  • balance disorder
  • hypersensitivity
  • insomnia
  • suicidal thoughts

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to prevent exposure to air or moisture and should be kept at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness and prevents deterioration.

Appearance and packaging

Appearance

Gray oval film-coated tablet

Package unit

30 tablets per bottle, 120 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.